Published in Cancer Weekly, November 21st, 2006
De Jager is a medical oncologist and clinical pharmacologist with more than 30 years of experience in the global development and successful registration of cancer therapeutics spanning multiple modalities.
De Jager joins Kosan from Conforma Therapeutics Corp. (acquired by Biogen Idec in May 2006) where he served as chief medical officer and vice president, clinical research and development, and was responsible for the company's development programs.
"Robert De Jager joins...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.